Inhibikase Therapeutics (IKT) Asset Utilization Ratio (2021 - 2024)
Inhibikase Therapeutics' (IKT) quarterly Asset Utilization Ratio came in at 0.0 in Q3 2024, down 100.0% year-on-year from 0.02 in Q4 2023, and down 100.0% on a QoQ basis from 0.01 in Q2 2024.
Inhibikase Therapeutics (IKT) Asset Utilization Ratio (2021 - 2024) Analysis & Trends
Inhibikase Therapeutics (IKT) has 4 years of Asset Utilization Ratio data on file, last reported at 0.0 in Q3 2024.
- On a quarterly basis, Asset Utilization Ratio fell 100.0% year-over-year to 0.0 in Q3 2024; TTM through Sep 2024 was 0.0, a 100.0% decrease from a year earlier, with the FY2023 full-year figure at 0.01, up 260.65% from the prior year.
- Asset Utilization Ratio for Q3 2024 stood at 0.0, down from 0.01 in the prior quarter.
- Over the last five years, Asset Utilization Ratio for IKT reached as high as 0.14 in Q1 2021 and fell as low as 0.0 in Q3 2024.
- Historically, Asset Utilization Ratio has averaged 0.03 across 4 years, with a median of 0.02 in 2024.
- Across the five-year window, Asset Utilization Ratio jumped 715.42% in 2023 and tumbled 100.0% in 2024, its largest moves.
- Year by year, Asset Utilization Ratio stood at 0.07 in 2021, then tumbled by 93.43% to 0.0 in 2022, then surged by 248.72% to 0.02 in 2023, then plunged by 100.0% to 0.0 in 2024.
- Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.0 in Q3 2024, 0.01 in Q2 2024, and 0.02 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.69 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.47 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.37 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Inhibikase Therapeutics | 55.25 Mn | -115.12 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 0.00 |
| Jun 30, 2024 | 0.01 |
| Mar 31, 2024 | 0.02 |
| Dec 31, 2023 | 0.02 |
| Sep 30, 2023 | 0.02 |
| Jun 30, 2023 | 0.01 |
| Mar 31, 2023 | 0.01 |
| Dec 31, 2022 | 0.00 |
| Sep 30, 2022 | 0.00 |
| Jun 30, 2022 | 0.01 |
| Mar 31, 2022 | 0.04 |
| Dec 31, 2021 | 0.07 |
| Sep 30, 2021 | 0.07 |
| Jun 30, 2021 | 0.10 |
| Mar 31, 2021 | 0.14 |